Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
Filter
Medientyp
Sprache
Region
Bibliothek
Erscheinungszeitraum
Person/Organisation
  • 1
    UID:
    almahu_9949982942602882
    Umfang: 1 online resource (684 pages)
    Ausgabe: Second edition.
    ISBN: 9780128243053 , 0128243058
    Serie: Woodhead Publishing series in biomedicine
    Inhalt: Managing the Drug Discovery Process, Second Edition thoroughly examines the current state of pharmaceutical research and development by providing experienced perspectives on biomedical research, drug hunting and innovation, including the requisite educational paths that enable students to chart a career path in this field. The book also considers the interplay of stakeholders, consumers, and drug firms with respect to a myriad of factors. Since drug research can be a high-risk, high-payoff industry, it is important to students and researchers to understand how to effectively and strategically manage both their careers and the drug discovery process. This new edition takes a closer look at the challenges and opportunities for new medicines and examines not only the current research milieu that will deliver novel therapies, but also how the latest discoveries can be deployed to ensure a robust healthcare and pharmacoeconomic future. All chapters have been revised and expanded with new discussions on remarkable advances including CRISPR and the latest gene therapies, RNA-based technologies being deployed as vaccines as well as therapeutics, checkpoint inhibitors and CAR-T approaches that cure cancer, diagnostics and medical devices, entrepreneurship, and AI. Written in an engaging manner and including memorable insights, this book is aimed at anyone interested in helping to save countless more lives through science. A valuable and compelling resource, this is a must-read for all students, educators, practitioners, and researchers at large-indeed, anyone who touches this critical sphere of global impact-in and around academia and the biotechnology/pharmaceutical industry. Considers drug discovery in multiple R&D venues - big pharma, large biotech, start-up ventures, academia, and nonprofit research institutes - with a clear description of the degrees and training that will prepare students well for a career in this arena Analyzes the organization of pharmaceutical R&D, taking into account human resources considerations like recruitment and configuration, management of discovery and development processes, and the coordination of internal research within, and beyond, the organization, including outsourced work Presents a consistent, well-connected, and logical dialogue that readers will find both comprehensive and approachable Addresses new areas such as CRISPR gene editing technologies and RNA-based drugs and vaccines, personalized medicine and ethical and moral issues, AI/machine learning and other in silico approaches, as well as completely updating all chapters.
    Anmerkung: Section A: Introduction and Overview -- 1. Backgrounder-Part 1 -- 2. Backgrounder-Part 2 Section B: Preprofessional Education -- 3. Introduction: Preprofessional education -- 4. Two-year certification and degree programs -- 5. Four-year undergraduate degree programs -- 6. The big decision Section C: Graduate and Professional Education -- 7. Graduate and postgraduate education at a crossroads -- 8. Master's degree programs -- 9. Doctoral and professional programs -- 10. The big leap Section D: Research and Discovery -- 11. Drug discovery: Standing on the shoulders of giants -- 12. Drug discovery processes: When and where the rubber meets the road -- 13. Drug discovery: Chaos can be your friend or your enemy -- 14. Research and discovery: Essential partners but just a start Section E: Chemical, Biological, and Healthcare Product Development, Quality Requirements, and Regulatory Affairs -- 15. Turning a potent agent-a chemical "drug"-into a registered product -- 16. Chemical development: Synthetic studies and engineering including aspects of batch production and continuous processing -- 17. Chemical development: Analytical studies -- 18. FDA path and process: Sponsor's regulatory tasks for drug approval -- 19. Development of biological and other healthcare products Section F: Pharmaceutical Research and Development: Concluding Remarks -- 20. Epilogue.
    Weitere Ausg.: Print version: Miller, Susan Managing the Drug Discovery Process San Diego : Elsevier Science & Technology,c2023 ISBN 9780128243046
    Sprache: Englisch
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Meinten Sie 012824305?
Meinten Sie 0128220058?
Meinten Sie 0128230568?
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie auf den KOBV Seiten zum Datenschutz